A defect of lipopolysaccharide-induced nitric oxide synthase gene expression in the paraventricular nucleus of Lewis rats

Endocrine Journal

Volumn 47, Issue 3, 2000, Pages 221-229

  Chikada, Naoko ^a   Imaki, Toshihiro ^a,b   Harada, Shoko ^a   Nakajima, Kishiko ^a   Naruse, Mitsuhide ^a   Yoshimoto, Takanobu ^a   Seki, Toshirou ^a   Tanabe, Akiyo ^a   Takano, Kazue ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Corticotrophin releasing factor; Lewis rat; Nitric oxide; NO synthase; Paraventricular nucleus

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; FEMALE; GENE EXPRESSION REGULATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; INFLAMMATORY DISEASE; NONHUMAN; RAT; THALAMUS MIDLINE NUCLEUS;

EID: 0033941275     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.47.221     Document Type: Article

References (45)

1. Calogero AE, Sternberg EM, Bagdy G, Smith C, Bernardini R, Aksentijevich S, Wilder RL, Gold PW, Chrousos GP (1992) Neurotransmitter-induced hypothalamic-pituitary-adrenal responsiveness in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting a global defect in CRH secretion. Neuroendocrinology 55: 600-608.
2. Sternberg EM, Hill JM, Chrousos GP, Kamolaris T, Listwak SJ, Gold PW, Wilder RL (1989) Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci USA 86: 2374-2378.
3. Sternberg EM, Young WS III, Bernardini R, Calogero AE, Chrousos GP, Gold PW, Wilder RL (1989) A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci USA 86: 4771-4775.
4. Sternberg EM, Glowa JR, Smith MA, Calogero AE, Listwak SJ, Aksentijevich S, Chrousos GP, Wilder RL, Gold PW (1992) Corticotropin releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fisher rats. Brain Res 570: 54-60.
5. Rivier CL, Plotsky PM (1986) Mediation by corticotropin-releasing factor (CRF) of adenohypophysial hormone secretion. Annu Rev Physiol 48: 475-494.
6. Sawchenko PE, Swanson LW (1990) Organization of CRF immunoreactive cells and fibers in rat brain: immunohistochemical studies. In DeSouza EB, Nemeroff CB (eds) Corticotropin-releasing factor: Basic and Clinical Studies of a Neuropeptide, Boca Raton, CRC Uniscience, 29-51.
7. Vale W, Spiess J, Rivier C, Rivier J (1982) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213: 1394-1397.
8. Nathan C, Xie QW (1994) Nitric oxide synthase: roles, tools, and controls (review). Cell 78: 915-918.
9. Costa A, Poma A, Navarra P, Forsling ML, Grossman A (1996) Gaseous transmitters as new agents in neuroendocrine regulation. J Endocrinol 149: 199-207.
10. Garthwaite J (1991) Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci 14: 60-67.
11. Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142.
12. Snyder SH, Bredt DS (1992) Biological roles of nitric oxide. Sci Am 266: 68-77.
13. Bredt DS, Glatt CE, Hwang PM (1991) Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 7: 615-624.
14. Grossman A, Rossmanith WG, Kabigting EB, Cadd G, Clifton D, Steiner RA (1994) The distribution of hypothalamic nitric oxide synthase mRNA in relation to gonadotropin-releasing hormone neurons. J Endocrinol 40: R5-R8.
15. Vincent SR, Kimura H (1992) Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 46: 599-603.
16. Lee S, Barbanel G, Rivier C (1995) Systemic endotoxin increases steady-state gene expression of hypothalamic nitric oxide synthase: comparison with corticotropin-releasing factor and vasopressin gene transcripts. Brain Res 705: 136-148.
17. Butterry LD, Evans TJ, Springall DR Carpenter A, Cohen J, Polaj JM (1994) Immunochemical localization of inducible nitric oxide synthase in endotoxin-treated rats. Lab Invest 71: 755-764.
18. Minc-Golomb D, Tsarfaty I, Schwartz JP (1994) Expression of inducible nitric oxide synthase by neurons following exposure to endotoxin and cytokine. Br J Pharmacol 112: 720-722.
19. Wong ML, Rettori V, al-Shekhlee A, Bongiorno PB, Canteros G, McCann SM, Gold PW, Licinio J (1996) Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nature Med 2: 581-584.
20. Harada S, Imaki T, Chikada N, Naruse M, Demura H (1999) Distinct distribution and time-course changes in neuronal nitric oxide (NO) synthase (nNOS) and inducible NOS (iNOS) in the paraventricular nucleus (PVN) following lipopolysaccharide (LPS) injection. Brain Res 821: 322-332.
21. Imaki T, Wang X-Q, Shibasaki T, Yamada K, Harada S, Chikada N, Naruse M, Demura H (1995) Stress-induced activation of neuronal activity and corticotropin-releasing factor gene expression in the paraventricular nucleus is modulated by glucocorticoids in rats. J Clin Invest 96: 231-238.
22. Imaki T, Wang X-Q, Shibasaki T, Harada S, Chikada N, Takahashi C, Naruse M, Demura H (1995) Chlordiazepoxide attenuates stress-induced activation of neurons, corticotropin-releasing factor (CRF) gene transcription and CRF biosynthesis in the paraventricular nucleus (PVN). Mol Brain Res 32: 261-270.
23. Paxinos G, Watson C (1986) The Rat Brain in Stereotaxic Coordinates, San Diego, Academic Press.
24. Calza L, Giardino L, Ceccateli A (1993) NOS mRNA in the paraventricular nucleus of young and old rats after immobilization stress. Neuroreport 4: 627-630.
25. Kishimoto J, Tsuchiya T, Emson PC, Nakayama Y (1996) Immobilization-induced stress activates neuronal nitric oxide synthase (nNOS) mRNA and protein in hypothalamic-pituitary-adrenal axis in rats. Brain Res 720: 158-171.
26. Milton NGN, Self H, Hillhouse EW (1993) Effects of pyrogenic immunomodulators on the release of corticotropin-releasing factor-41 and prostaglandin E2 from the intact rat hypothalamus in vitro. Br J Pharmacol 109: 8893-8898.
27. Pozzoli G, Costa A, Grimaldi M, Schettini G, Preziosi P, Grossman A, Navarra P (1994) Lipopolysaccharide modulation of eicosanoid and corticotropin-releasing hormone release from rat hypothalamic explants and astrocyte cultures in vitro: evidence for the involvement of prostaglandin E2 but not prostaglandin F2α and lack of effect of nerve growth factor. J Endocrinol 140: 103-109.
28. Torres G, Lee S, Rivier C (1993) Ontogeny of the rat nitric oxide synthase and colocalization with neuropeptides Mol Cell Neurosci 4: 155-163.
29. Wood J, Garthwaite J (1994) Models of the diffusional spread of nitric oxide: implications for neural nitric oxide signaling and its pharmacological properties. Neuropharmacology 33: 1235-1244.
30. Brunetti L, Preziosi P, Ragazzoni E, Vacca M (1993) Involvement of nitric oxide in basal and interleukin β-induced CRH and ACTH release in vitro. Life Sci 53: 219-222.
31. Sandi C, Guaza C (1995) Evidence for a role of nitric oxide in the corticotropin-releasing factor release induced by interleukin-1β. Eur J Pharmacol 274: 17-23.
32. Kim CK, Rivier C (1988) Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals. J Neuroimmunol 10: 353-362.
33. Costa A, Trainer P, Besser M, Grossman A (1993) Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro. Brain Res 605: 187-192.
34. Kostoglou-Athanassiou I, Costa A, Navarra P, Nappi G, Forsling ML, Grossman AB (1988) Endotoxin stimulates an endogenous pathway regulating corticotropin-releasing hormone and vasopressin release involving the generation of nitric oxide and carbon monoxide. J Neuroimmunol 86: 104-109.
35. Rivier C (1994) Endogenous nitric oxide participates in the activation of the hypothalamic-pituitary adrenal axis by noxious stimuli. Endocr J 2: 363-373.
36. Grossman AB, Costa A, Forsling ML, Jacobs R, Kostoglou-Athanassiou I, Nappi G, Navarra P, Satta MA (1997) Gaseous neurotransmitters in the hypothalamus. Horm Metab Res 29: 477-482.
37. Salvenimi D, Misko TP, Masferre JL, Seibert K, Currie MG, Needleman P (1993) Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90: 7240-7243.
38. Mancuso C, Tringali G, Grossman A, Preziosi P, Navarra P (1988) The generation of nitric oxide and carbon monoxide produces opposite effects on the release of immunoreactive interleukin-1β from the rat hypothalamus in vitro: evidence for the involvement of different signaling pathways. Endocrinology 139: 1031-1037.
39. Ceccateli S, Lundberg JM, Fahrenkrug J, Bredt DS, Snyder SH, Hokfelt T (1992) Evidence for involvement of nitric oxide in the regulation of hypothalamic portal blood flow. Neurosci 51: 769-772.
40. Horn T, Smith PM, Mclaughlin BE, Bauce L, Marks GS, Pittman QJ. Ferguson AV (1994) Nitric oxide actions in paraventricular nucleus: cardiovascular and neurochemical implications. Am J Physiol 266: R306-R313.
41. Spitsin SV, Koprowski K, Michaels FH (1996) Characterization and functional analysis of the human inducible nitric oxide synthase gene promoter. Mol Med 2: 226-235.
42. Tilders FJ, DeRijik RH, Van Dam A, Vincent VA, Shitanus K, Persoons JH (1994) Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxin, routes and intermediate signals. Psychoneuroendocrinology 19: 209-232.
43. Karanth S, Lyson K, McCann SM (1993) Role of nitric oxide in interleukin-2-induced corticotropin-releasing factor release from incubated hypothalami. Proc Natl Acad Sci USA 90: 3383-3387.
44. Elmquist JK, Saper CB (1996) Activation of neurons projecting to the paraventricular hypothalamic nucleus by intravenous lipopolysaccharide. J Comp Neurol 374: 315-331.
45. Bluthe RM, Walter V, Parnet P, Laye S, Lestage J, Verrier D, Poole S, Stenning BE, Kelley KW, Dantzer R (1994) Lipoplysaccharide induces sickness behavior in rats by a vagal mediated mechanism. C R Acad Sci 317: 499-503